Compositions and their uses directed to PTPR alpha
US8158598B2 · kind B2 · utility
19Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2007 |
| Grant date | Apr 17, 2012 |
| Priority date | — |
| Expiry date | Apr 19, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/345
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds, compositions and methods for modulating the expression of PTPR.alpha. in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of airway hyperresponsiveness and pulmonary inflammation by administration of antisense compounds targeted to PTPR.alpha.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.